Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Benz

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Toxicology Mechanisms and Methods|December 22, 2009
Combined Use of MC4PC, MDL-QSAR, BioEpisteme, Leadscope PDM, and Derek for Windows Software to Achieve High-Performance, High-Confidence, Mode of Action-Based Predictions of Chemical Carcinogenesis in RodentsEdwin J Matthews, Naomi L Kruhlak, R Daniel Benz, et al.
Scientific Reports|May 17, 2024
Comparison of 8-vs-12 weeks, adapted dialectical behavioral therapy (DBT) for borderline personality disorder in routine psychiatric inpatient treatment-A naturalistic studyMilenko Kujovic, Daniel Benz, Mathias Riesbeck, et al.
Regulatory Toxicology and Pharmacology : RTP|May 8, 2009
Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans. Part A: use of FDA post-market reports to create a database of hepatobiliary and urinary tract toxicitiesCarling J Ursem, Naomi L Kruhlak, Joseph F Contrera, et al.
Regulatory Toxicology and Pharmacology : RTP|May 8, 2009
Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part C: use of QSAR and an expert system for the estimation of the mechanism of action of drug-induced hepatobiliary and urinary tract toxicitiesEdwin J Matthews, Naomi L Kruhlak, R Daniel Benz, et al.
Borderline Personality Disorder and Emotion Dysregulation|January 14, 2025
Effects on impulsivity and delay discounting of intermittent theta burst stimulation add-on to dialectical behavioral therapy in borderline personality disorder: a randomized, sham-controlled pilot trialMilenko Kujovic, Christian Bahr, Mathias Riesbeck, et al.
Environmental and Molecular Mutagenesis|May 4, 2011
Genetic toxicology in the 21st century: reflections and future directionsBrinda Mahadevan, Ronald D Snyder, Michael D Waters, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 19, 2024
Effects of intermittent theta burst stimulation add-on to dialectical behavioral therapy in borderline personality disorder: results of a randomized, sham-controlled pilot trialMilenko Kujovic, Christian Bahr, Mathias Riesbeck, et al.
Regulatory Toxicology and Pharmacology : RTP|May 8, 2009
Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicitiesEdwin J Matthews, Carling J Ursem, Naomi L Kruhlak, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 14, 2023
Theta burst stimulation add on to dialectical behavioral therapy in borderline-personality-disorder: methods and design of a randomized, single-blind, placebo-controlled pilot trialMilenko Kujovic, Daniel Benz, Mathias Riesbeck, et al.
Neuropsychiatric Disease and Treatment|May 1, 2025
Beyond Anxiety and Depression: Multidimensional Psychiatric Screening for Neurological Patients Based on HADS and BSI-53Milenko Kujovic, Daniel Benz, Bruno Baumann, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Toxicology Mechanisms and Methods|December 22, 2009
Combined Use of MC4PC, MDL-QSAR, BioEpisteme, Leadscope PDM, and Derek for Windows Software to Achieve High-Performance, High-Confidence, Mode of Action-Based Predictions of Chemical Carcinogenesis in RodentsEdwin J Matthews, Naomi L Kruhlak, R Daniel Benz, et al.
Scientific Reports|May 17, 2024
Comparison of 8-vs-12 weeks, adapted dialectical behavioral therapy (DBT) for borderline personality disorder in routine psychiatric inpatient treatment-A naturalistic studyMilenko Kujovic, Daniel Benz, Mathias Riesbeck, et al.
Regulatory Toxicology and Pharmacology : RTP|May 8, 2009
Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans. Part A: use of FDA post-market reports to create a database of hepatobiliary and urinary tract toxicitiesCarling J Ursem, Naomi L Kruhlak, Joseph F Contrera, et al.
Regulatory Toxicology and Pharmacology : RTP|May 8, 2009
Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part C: use of QSAR and an expert system for the estimation of the mechanism of action of drug-induced hepatobiliary and urinary tract toxicitiesEdwin J Matthews, Naomi L Kruhlak, R Daniel Benz, et al.
Borderline Personality Disorder and Emotion Dysregulation|January 14, 2025
Effects on impulsivity and delay discounting of intermittent theta burst stimulation add-on to dialectical behavioral therapy in borderline personality disorder: a randomized, sham-controlled pilot trialMilenko Kujovic, Christian Bahr, Mathias Riesbeck, et al.
Environmental and Molecular Mutagenesis|May 4, 2011
Genetic toxicology in the 21st century: reflections and future directionsBrinda Mahadevan, Ronald D Snyder, Michael D Waters, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 19, 2024
Effects of intermittent theta burst stimulation add-on to dialectical behavioral therapy in borderline personality disorder: results of a randomized, sham-controlled pilot trialMilenko Kujovic, Christian Bahr, Mathias Riesbeck, et al.
Regulatory Toxicology and Pharmacology : RTP|May 8, 2009
Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicitiesEdwin J Matthews, Carling J Ursem, Naomi L Kruhlak, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 14, 2023
Theta burst stimulation add on to dialectical behavioral therapy in borderline-personality-disorder: methods and design of a randomized, single-blind, placebo-controlled pilot trialMilenko Kujovic, Daniel Benz, Mathias Riesbeck, et al.
Neuropsychiatric Disease and Treatment|May 1, 2025
Beyond Anxiety and Depression: Multidimensional Psychiatric Screening for Neurological Patients Based on HADS and BSI-53Milenko Kujovic, Daniel Benz, Bruno Baumann, et al.
Pageof 4